UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000017669 |
|---|---|
| Receipt number | R000020483 |
| Scientific Title | Safety of canagliflozin in diabetic patients with chronic heart failure: randomized, non-inferiority trial |
| Date of disclosure of the study information | 2015/05/25 |
| Last modified on | 2022/08/25 14:17:04 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/05/25 16:28:36 | ||
| 2 | Update | 2015/06/08 15:40:50 | Institutions |
|
| 3 | Update | 2015/08/13 16:21:15 | Institutions |
|
| 4 | Update | 2015/10/02 17:46:58 | Key secondary outcomes Key secondary outcomes |
|
| 5 | Update | 2015/10/02 17:48:37 | Institutions |
|
| 6 | Update | 2015/11/18 09:26:50 | Institutions |
|
| 7 | Update | 2015/11/18 09:27:32 | Recruitment status |
|
| 8 | Update | 2016/05/16 16:47:21 | Name of primary person or sponsor Organization Email1 |
|
| 9 | Update | 2016/06/06 17:35:21 | Institutions |
|
| 10 | Update | 2016/06/06 17:36:19 | Randomization unit |
|
| 11 | Update | 2016/07/19 15:00:09 | Institutions |
|
| 12 | Update | 2017/07/27 10:47:24 | Recruitment status |
|
| 13 | Update | 2017/07/27 10:49:47 | Organization Organization Division name Division name |
|
| 14 | Update | 2018/05/18 15:42:15 | Institutions |
|
| 15 | Update | 2019/03/13 10:18:06 | UMIN ID1 |
|
| 16 | Update | 2019/03/13 12:03:07 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Zip code Last name of contact person Last name of contact person Division name Zip code Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Email1 Organization Organization Address Address Tel |
|
| 17 | Update | 2019/05/28 13:40:40 | Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete |
|
| 18 | Update | 2020/07/29 16:35:01 | Recruitment status |
|
| 19 | Update | 2020/07/29 16:41:05 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 20 | Update | 2022/08/25 14:17:04 | Recruitment status |
